RVNC
Revance Therapeutics Inc
Price:  
2.80 
USD
Volume:  
1,458,811.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RVNC Fair Value

-642.56 %
Upside

As of 2024-06-18, the Fair Value of Revance Therapeutics Inc (RVNC) is -15.19 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 2.80 USD, the upside of Revance Therapeutics Inc is -642.56%.

Note: valuation result may not be accurate due to the company's negative EPS.

2.80 USD
Stock Price
-15.19 USD
Fair Price
FAIR VALUE CALCULATION

RVNC Fair Value

Peter Lynch's formula is:

RVNC Fair Value
= Earnings Growth Rate x TTM EPS
RVNC Fair Value
= 5.00 x -3.04
RVNC Fair Value
= -15.19

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31 5Y Avg
Net income -159.40 -282.10 -281.30 -356.40 -323.99 -280.64
YoY growth -11.78% -76.98% 0.28% -26.70% 9.09% -21.22%

RVNC Fair Value - Key Data

Market Cap (mil) 292.46
P/E
Forward P/E
EPS -3.04
Avg earnings growth rate -21.22%
TTM earnings -317.35